1.
Dr Gaurav Thukral, Dr Vipulkumar Thummar, Dr Priya Mehta, Dr. Vijay Janagama, Keyur Khambhati. Drug Utilization Pattern of World’s First T-DM1 Biosimilar (UJVIRATM) For Her2+ Breast Cancer in First Year of Its Availability – An Indian Context. ijmsci [Internet]. 2023 Feb. 25 [cited 2024 Aug. 26];10(02):6561-8. Available from: https://valleyinternational.net/index.php/ijmsci/article/view/3850